Disease Info Card

Trichoepithelioma

Information about Trichoepithelioma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Trichoepithelioma

Most recent studies have shown that Trichoepithelioma shares some biological mechanisms with adenoid-cystic-carcinoma, basal-cell-carcinoma, basal-cell-neoplasm, benign-neoplasm, carcinoma, carcinoma-skin-appendage, dermatologic-disorders, desmoplastic, desmoplastic-trichoepithelioma, epithelioma, facial-neoplasms, hair-diseases, hamartoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, melanocytic-nevus, neoplasms, neoplasms-adnexal-and-skin-appendage, neoplasms-multiple-primary, skin-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Trichoepithelioma, and have been seen in publications frequently: Anagen, Catagen, Cell Cycle, Cell Differentiation, Cell Growth, Cell Proliferation, Hair Cycle, Hair Follicle Development, Inflammatory Response, Invasive Growth, Keratinization, Localization, Ossification, Pathogenesis, Pigmentation, Secretion, Skin Development, Spermatogenesis, Telogen

Quite a number of genes have been found to play important roles in Trichoepithelioma, such as AR, BCL2, CD34, CHKA, CHKB, CYLD, ETFA, GNL3, IVL, KRT15, KRT19, KRT20, KRT5, KRT7, MME, MUC1, PHLDA1, PTCH1, TP53. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.